头颈部鳞状细胞癌-话题@MedSci

#头颈部鳞状细胞癌#

55篇内容 | 3139人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1297709, encodeId=0d02129e70927, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后, objectType=article, longId=201449, objectId=7c8f201449ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c8f201449ff, replyNumber=0, likeNumber=72, createdTime=2020-10-03, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c8f201449ff, moduleTitle=Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c8f201449ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297708, encodeId=74bf129e708f1, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖, objectType=article, longId=201185, objectId=f7e020118541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7e020118541, replyNumber=0, likeNumber=64, createdTime=2020-09-26, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7e020118541, moduleTitle=Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7e020118541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297707, encodeId=5332129e707e8, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, objectType=article, longId=198710, objectId=a8d7198e10e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8d7198e10e3, replyNumber=0, likeNumber=50, createdTime=2020-08-06, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8d7198e10e3, moduleTitle=Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8d7198e10e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297706, encodeId=44c5129e7060f, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果, objectType=article, longId=198497, objectId=df1419849e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df1419849e05, replyNumber=0, likeNumber=68, createdTime=2020-08-02, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df1419849e05, moduleTitle=Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df1419849e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297705, encodeId=2344129e7058b, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析, objectType=article, longId=196280, objectId=fe3c1962807f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe3c1962807f, replyNumber=0, likeNumber=64, createdTime=2020-06-24, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe3c1962807f, moduleTitle=J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe3c1962807f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297704, encodeId=be18129e7045e, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=J Otolaryngol Head Neck Surg：术前免疫营养有利于减少复发性头颈部鳞状细胞癌患者抢救性手术后的并发症, objectType=article, longId=196254, objectId=3945196254f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3945196254f1, replyNumber=0, likeNumber=77, createdTime=2020-06-24, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3945196254f1, moduleTitle=J Otolaryngol Head Neck Surg：术前免疫营养有利于减少复发性头颈部鳞状细胞癌患者抢救性手术后的并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3945196254f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297703, encodeId=47e3129e703b5, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Molecules：石斛中Moscatilin可用于治疗头颈部鳞状细胞癌, objectType=article, longId=188690, objectId=043a188690de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=043a188690de, replyNumber=0, likeNumber=78, createdTime=2020-02-25, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=043a188690de, moduleTitle=Molecules：石斛中Moscatilin可用于治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=043a188690de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297702, encodeId=6579129e7026e, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌, objectType=article, longId=186378, objectId=17ce1863e8ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ce1863e8ed, replyNumber=0, likeNumber=64, createdTime=2020-01-18, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ce1863e8ed, moduleTitle=英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17ce1863e8ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297701, encodeId=218e129e70115, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Cell Death Dis：BH3类似物治疗头颈部鳞状细胞癌的潜能, objectType=article, longId=185075, objectId=03531850e54f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03531850e54f, replyNumber=0, likeNumber=58, createdTime=2019-12-24, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03531850e54f, moduleTitle=Cell Death Dis：BH3类似物治疗头颈部鳞状细胞癌的潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03531850e54f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297700, encodeId=af63129e700ae, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=美国SITC发布，头颈部鳞状细胞癌免疫治疗专家共识, objectType=article, longId=182804, objectId=d88f182804ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88f182804ee, replyNumber=0, likeNumber=71, createdTime=2019-11-12, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88f182804ee, moduleTitle=美国SITC发布，头颈部鳞状细胞癌免疫治疗专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88f182804ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297699, encodeId=acb1129e699c0, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Lancet：Pembrolizumab治疗复发或转移性头颈部鳞状细胞癌, objectType=article, longId=182385, objectId=dc141823856a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc141823856a, replyNumber=0, likeNumber=63, createdTime=2019-11-06, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc141823856a, moduleTitle=Lancet：Pembrolizumab治疗复发或转移性头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc141823856a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297698, encodeId=d28f129e69813, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Clin Chem：循环肿瘤细胞作为复发或转移性头颈部鳞状细胞癌的预后因素？, objectType=article, longId=181846, objectId=37b0181846f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37b0181846f1, replyNumber=0, likeNumber=66, createdTime=2019-10-25, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37b0181846f1, moduleTitle=Clin Chem：循环肿瘤细胞作为复发或转移性头颈部鳞状细胞癌的预后因素？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37b0181846f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297697, encodeId=0904129e6972a, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌, objectType=article, longId=159008, objectId=21e215900857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21e215900857, replyNumber=0, likeNumber=55, createdTime=2019-01-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e215900857, moduleTitle=CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21e215900857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297696, encodeId=dafd129e696f9, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=JAMA ONCOL：PD-L低表达的复发或转移头颈部鳞状细胞癌患者接受Durvalumab联合Tremelimumab治疗的安全性和有效性, objectType=article, longId=153283, objectId=aa13153283e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa13153283e8, replyNumber=0, likeNumber=61, createdTime=2018-11-13, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa13153283e8, moduleTitle=JAMA ONCOL：PD-L低表达的复发或转移头颈部鳞状细胞癌患者接受Durvalumab联合Tremelimumab治疗的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa13153283e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297695, encodeId=d9cf129e695f7, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, objectType=article, longId=141953, objectId=6d9f14195367, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d9f14195367, replyNumber=0, likeNumber=37, createdTime=2018-07-01, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d9f14195367, moduleTitle=CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d9f14195367)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297694, encodeId=648e129e69438, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：头颈部鳞状细胞癌患者分子改变情况及Buparlisib疗效, objectType=article, longId=140468, objectId=9e50140468bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e50140468bb, replyNumber=0, likeNumber=66, createdTime=2018-06-12, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e50140468bb, moduleTitle=CLIN CANCER RES：头颈部鳞状细胞癌患者分子改变情况及Buparlisib疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e50140468bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297693, encodeId=1100129e69382, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=JAMA Oncol：口腔微生物是否影响头颈部鳞状细胞癌风险？, objectType=article, longId=137811, objectId=d7ea13e81138, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7ea13e81138, replyNumber=0, likeNumber=71, createdTime=2018-05-12, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7ea13e81138, moduleTitle=JAMA Oncol：口腔微生物是否影响头颈部鳞状细胞癌风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7ea13e81138)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297692, encodeId=01c8129e69218, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：厚朴酚通过下调存活素增加头颈部鳞状细胞癌放疗敏感性, objectType=article, longId=130872, objectId=2eec1308e2de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eec1308e2de, replyNumber=0, likeNumber=75, createdTime=2018-03-01, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eec1308e2de, moduleTitle=CLIN CANCER RES：厚朴酚通过下调存活素增加头颈部鳞状细胞癌放疗敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eec1308e2de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297691, encodeId=3ae8129e691db, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：CD271通过上调Slug促进头颈部鳞状细胞癌侵袭和转移, objectType=article, longId=130665, objectId=a0e3130665c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e3130665c9, replyNumber=0, likeNumber=74, createdTime=2018-02-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e3130665c9, moduleTitle=CLIN CANCER RES：CD271通过上调Slug促进头颈部鳞状细胞癌侵袭和转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0e3130665c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297690, encodeId=407f129e690f4, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化, objectType=article, longId=130634, objectId=6672130634b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6672130634b8, replyNumber=0, likeNumber=103, createdTime=2018-02-27, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6672130634b8, moduleTitle=CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6672130634b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

头颈部鳞状细胞癌

2020-05-29

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Br J Cancer：Buparlisib和西妥昔单抗联合治疗改善头颈部鳞状细胞癌患者预后

2020-10-03

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Nat Commun：VAV2促进皮肤和头颈部鳞状细胞癌的再生性增殖

2020-09-26

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Lancet oncol：Debio 1143治疗局部晚期头颈部鳞状细胞癌

2020-08-06

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Cancer：二甲双胍联合顺铂和放疗治疗局部晚期头颈部鳞状细胞癌的效果

2020-08-02

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

J Immunother Cancer：抗PD1单药治疗头颈部鳞状细胞癌患者三期临床试验的比较分析

2020-06-24

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

J Otolaryngol Head Neck Surg：术前免疫营养有利于减少复发性头颈部鳞状细胞癌患者抢救性手术后的并发症

2020-06-24

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Molecules：石斛中Moscatilin可用于治疗头颈部鳞状细胞癌

2020-02-25

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

英国NICE拒绝将PD-1单抗Keytruda，用于转移或复发的头颈部鳞状细胞癌

2020-01-18

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Cell Death Dis：BH3类似物治疗头颈部鳞状细胞癌的潜能

2019-12-24

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

美国SITC发布，头颈部鳞状细胞癌免疫治疗专家共识

2019-11-12

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Lancet：Pembrolizumab治疗复发或转移性头颈部鳞状细胞癌

2019-11-06

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Clin Chem：循环肿瘤细胞作为复发或转移性头颈部鳞状细胞癌的预后因素？

2019-10-25

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：Patritumab联合西妥昔单抗和铂类治疗头颈部鳞状细胞癌

2019-01-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

JAMA ONCOL：PD-L低表达的复发或转移头颈部鳞状细胞癌患者接受Durvalumab联合Tremelimumab治疗的安全性和有效性

2018-11-13

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：AZD1775联合新辅助多西他赛和顺铂治疗头颈部鳞状细胞癌

2018-07-01

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：头颈部鳞状细胞癌患者分子改变情况及Buparlisib疗效

2018-06-12

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

JAMA Oncol：口腔微生物是否影响头颈部鳞状细胞癌风险？

2018-05-12

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：厚朴酚通过下调存活素增加头颈部鳞状细胞癌放疗敏感性

2018-03-01

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：CD271通过上调Slug促进头颈部鳞状细胞癌侵袭和转移

2018-02-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化

2018-02-27

科室
- - 订阅+
  - 更多科室
工具
服务